Findings newly published in the Journal of Neurology, Neurosurgery & Psychiatry indicated that the long-standing clinical ...

Median monthly countable seizure frequency reductions were sustained through week 52 after a single ETX101 administration, with notable month-12 decreases among participants completing 52 weeks.

Neurology moves fast, and the assumptions that shape how we practice do not always keep up. Gray Areas is a new NeurologyLive series where leading clinicians and researchers challenge widely held ...

The clinical complexity of epilepsy often extends well beyond seizures. Depression, anxiety, suicidality, cognitive ...

A new study suggests excessive daytime sleepiness in obstructive sleep apnea may be associated with cognitive impairment and ...

A 72% prevalence of excessive daytime sleepiness was identified using PDSS ≥15 among 1,616 adolescents aged 14–19 years in 20 ...

Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group | Peer Exchange | NeurologyLive is your direct connection to the latest neurology news and interviews with expert ...

A global, randomized, double-blind phase 3 program in ~150 DM1 patients dosed every 8 weeks did not significantly improve vHOT, a hand myotonia endpoint, versus placebo. Secondary endpoints included ...

NeurologyLive Brain Games is a weekly quiz series that goes live every Sunday morning, featuring questions on a variety of ...

A lymphocyte-count polygenic score derived from Pan-UK Biobank GWAS data was inversely associated with grade 2 lymphopenia ...

Findings from a new study showed that over 90% of counties in the United States lacked a UCNS-certified headache specialist, ...

Progressive supranuclear palsy (PSP) is a rare, progressive neurodegenerative disorder characterized by parkinsonism ...